🇺🇸 Dutasteride/Tamsulosin in United States
666 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 666
Most-reported reactions
- Death — 92 reports (13.81%)
- Dizziness — 87 reports (13.06%)
- Hypotension — 72 reports (10.81%)
- Gait Disturbance — 64 reports (9.61%)
- Constipation — 61 reports (9.16%)
- Diarrhoea — 59 reports (8.86%)
- Fatigue — 59 reports (8.86%)
- Drug Ineffective — 58 reports (8.71%)
- Fall — 57 reports (8.56%)
- Pyrexia — 57 reports (8.56%)
Other Urology approved in United States
Frequently asked questions
Is Dutasteride/Tamsulosin approved in United States?
Dutasteride/Tamsulosin does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Dutasteride/Tamsulosin in United States?
GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.